Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feiba in Congenital Hemophilia A Patients With Inhibitors on Emicizumab
NCT04205175Phase 4Active, not recruiting
- Sponsor
- Children's Hospital Los Angeles
- Start
- Jul 2020
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of anti-inhibitor coagulant complex in hemophilia A, sponsored by Children's Hospital Los Angeles. Started Jul 2020; status: active, not recruiting.
02
Drugs
anti-inhibitor coagulant complex
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT04205175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205175.